Stockreport

Xenon Reports Q2 2024 Financial Results and Business Update [Financial Post (Toronto, Ontario, Canada)]

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
PDF — Phase 3 epilepsy program progressing with X-TOLE2 topline FOS data anticipated in H2 2025 — MDD program on track with Phase 3 study expected to initiate in H2 2024 [Read more]